Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there. Did your doctor somehow miss the recovery protocol that Pedro Bach-y-Rita used to recover fully back in 1958 with only a partial brain?

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Tuesday, November 17, 2026

Efficacy of Repetitive Transcranial Magnetic Stimulation in Preventing Poststroke Spasticity: A Sham-Controlled Trial

 Lowered is NOT GOOD ENOUGH! Where is the EXACT CURE for spasticity? When you are the 1 in 4 per WHO that has a stroke you'll want it cured! Your comeuppance when you don't recover will be soul-satisfying for all the stroke survivors that came before and after you and didn't recover!

I'd fire you for incompetence in not curing spasticity!

Efficacy of Repetitive Transcranial Magnetic Stimulation in Preventing Poststroke Spasticity: A Sham-Controlled Trial


Abstract

BACKGROUND:

Poststroke spasticity significantly impairs recovery, yet preventive strategies remain limited. This study evaluated the effectiveness of repetitive transcranial magnetic stimulation (rTMS) in reducing the development and severity of spasticity in patients with early subacute stroke, offering a possible early intervention.

In this double-blind, randomized, sham-controlled trial, 70 patients with early subacute stroke (7–30 days) were randomized to receive 3 sessions of low-frequency (1 Hz, 1000 pulses at 90% resting motor threshold) rTMS over contralesional primary motor cortex (n=35) or sham stimulation (n=35), alongside standard care. The primary outcome was upper-limb spasticity assessed using the modified Modified Ashworth Scale. Secondary outcomes included handgrip strength, muscle power assessed by the Medical Research Council scale, pain assessed by the Visual Analogue Scale, modified Rankin Scale, and Stroke Impact Scale 3.0.

RESULTS:

rTMS therapy significantly lowered spasticity scores at 1 and 3 months across all assessed upper-limb joints (P=0.001), improved handgrip strength (P=0.01), and prevented pain (P=0.001). Stroke Impact Scale scores at 1 month showed greater gains in activities of daily living, mobility, hand function, social participation, and recovery in the rTMS group (P=0.001). Functional independence (modified Rankin Scale) was significantly better in the rTMS group (P=0.006) at 3 months. On binary logistic regression, sham stimulation was associated with greater odds of developing spasticity at 1 month (shoulder odds ratio [OR], 8.29 [95% CI, 1.95–35.27], P=0.04; elbow OR, 7.62 [95% CI, 1.69–34.35], P=0.08; wrist OR, 5.18 [95% CI, 1.60–16.78], P=0.06). At 3 months, sham stimulation remained predictive, with higher odds of spasticity at the shoulder (OR, 15.3 [95% CI, 8.26–28.43]), elbow (OR, 13.43 [95% CI, 3.94–45.78]), wrist (OR, 19.9 [95% CI, 4.9–80.96]), and fingers (OR, 26.25 [95% CI, 5.19–132.87], all P=0.001). Minor adverse events like headache and light-headedness were observed in 5 patients.

CONCLUSIONS:

Low-frequency rTMS over contralesional primary motor cortex significantly prevented spasticity, improved motor recovery, reduced pain, improved functional outcomes and quality of life in early subacute stroke, supporting its role as a promising adjunctive therapy in early stroke rehabilitation.

REGISTRATION:

URL: https://ctri.nic.in/; Unique identifier: CTRI/2024/01/061225.

Graphical Abstract



Get full access to this article

No comments:

Post a Comment